Faculty

Joshua Berlin
Executive Director Business Development
BioCentury Inc.
Karen Bernstein, Ph.D.
Chairman
BioCentury Inc.
Kate Bingham
Managing Partner
SV Health Investors
Paul Bonanos
Associate Editor
BioCentury Inc.
Michael Booth, Ph.D.
CFO
Crescendo Biologics Ltd.
Simone Botti, Ph.D.
Junior Partner
Inkef Capital
Eduardo Bravo
CEO
European Biotech Acquisition Corp.
Sascha-Oliver Bucher
Co-founder & Partner
Forty51 Ventures
Roel Bulthuis
Managing Partner & Head of Healthcare Investment
Inkef Capital
Simon Chandler, Ph.D.
CEO
Rinri Therapeutics Ltd.
Tony Chen
Chairman
BayHelix & Partner, Jones Day
Jeff Cranmer
Executive Editor and Head of Daily Global Intelligence
BioCentury Inc.
Sabine Dandiguian
Managing Partner
Jeito Capital
Jan De Kerpel, Ph.D.
Managing Director
Kempen & Co.
Cris De Luca
Global Head, Digital Investments
Sanofi Ventures
Valerio De Molli
Managing Partner & CEO
The European House - Ambrosetti
Francesco De Rubertis Ph.D.
Co-founder and Partner
Medicxi
David Dobkin
Managing Director, LifeSci Capital, and CFO, LifeSci Acquisition Corp. and LifeSci Acquisition II Corp.
LifeSci Capital
Sergio Dompé
CEO
Dompé farmaceutici, and Chair, B20 Task Force Health and Life Sciences
Simone Fishburn, Ph.D.
Vice President and Editor in Chief
BioCentury Inc.
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Arthur Franken
General Partner
Gilde Healthcare
Aoife Gallagher, Ph.D.
Head of Innovation
RCSI University of Medicine and Health Sciences
Robert Garber
Partner
7wireVentures
Taylor Guo, Ph.D.
Chief Scientific Officer
I-Mab Biopharma Co.
Stephen Hansen
Associate Editor
BioCentury Inc.
Theodora Harold
CEO
Crescendo Biologics
Wei-Wu He, Ph.D.
Chairman & CEO
CASI Pharmaceuticals Inc.
Rudiger Herrmann, Ph.D.
Partner
Squire Patton Boggs
Echo Hindle-Yang
Founder & CEO
MSQ Ventures
Will Hoh
Managing Director, Investment Banking, M&A and Strategic Advisory Services
H.C. Wainwright & Co.
Steve Hurly
CEO
Lava Therapeutics N.V.
Alicia Irurzun-Lafitte
Partner
UCB Ventures
Derek John, Ph.D.
Technology Transfer Case Manager
RCSI University of Medicine and Health Sciences
Henk Joos, Ph.D.
General Manager
Agio Capital & Business Solutions
Frank Kalkbrenner, Ph.D.
Global Head
Boehringer Ingelheim Venture Fund
Dirk Kersten
General Partner
Forbion
Michael Keyoung, M.D., Ph.D.
Managing Director & Head of North America
CBC Group
David Klein
CEO
Click Therapeutics Inc.
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Sophie Kornowski, Pharm.D.
Senior Partner
Gurnet Point Capital
Arthur Lahr
Former CEO
Kiadis Pharma N.V.
Werner Lanthaler, Ph.D.
CEO
Evotec AG
Virginia Li
Associate Editor
BioCentury Inc.
Andrew Limouris
CEO
Medix
Carsten Linnemann, Ph.D.
Co-founder, President & CEO
Neogene Therapeutics Inc.
Da Liu
Managing Director
CR-CP Life Science Fund
Alberto Loche, Ph.D.
Associate Partner
McKinsey & Co.
William Love, Ph.D.
Founder & Chief Scientific Officer
Destiny Pharma Ltd.
Anker Lundemose, M.D., Ph.D.
CEO
Mission Therapeutics Ltd.
Nanna Luneborg, Ph.D.
Partner
Novo Ventures
Vanessa Malier
Partner
Kurma Partners
Allan Marchington, Ph.D.
Managing Director & Head of Life Sciences
Intermediate Capital Group plc
Lauren Martz
Senior Editor, Head of Translation & Clinical Development
BioCentury Inc.
Anant Murthy, Ph.D.
General Manager Europe
argenx S.E.
Carole Nuechterlein
Head, Roche Venture Fund
Roche
Alan O'Connell, Ph.D.
Partner
Seroba
Stefan Oelrich
Head, Pharmaceuticals
Bayer AG
Anne Osdoit
Partner
Sofinnova Partners
Antoine Papiernik
Chairman and Managing Partner
Sofinnova Partners
Eric Pierce
Publisher
BioCentury Inc.
Steven Powell, Ph.D.
CEO
eTheRNA immunotherapies N.V.
Pam Putz
Managing Director
EBD Group
John Rex, M.D.
Chief Medical Officer & Director, F2G Ltd. and Editor in Chief, AMR Solutions
F2G Ltd.
Henrijette Richter, Ph.D.
Managing Partner
Sofinnova Partners
Joachim Rothe, Ph.D.
Managing Partner
LSP
Giuseppe Sala
Mayor of Milan
Milan, Italy
Jorge Santos da Silva, Ph.D.
Senior Partner
McKinsey & Company
Graziano Seghezzi
Managing Partner
Sofinnova Partners
Henry Skinner, Ph.D.
CEO
AMR Action Fund
Jeff Smith
Partner & Global Leader, Cell & Gene Therapy
McKinsey & Co.
Bobby G. Soni, Ph.D.
CBO
BioInnovation Institute
Karen Tkach Tuzman, Ph.D.
Senior Editor, Head of Discovery & Preclinical Development
BioCentury Inc.
Rafaèle Tordjman, M.D., Ph.D.
Founder & CEO
Jeito Capital
Andreas Typaldos
CEO
Petra Acquisition Inc.
Marina Udier, Ph.D.
CEO
Nouscom AG
Steve Usdin
Washington Editor & Head Policy and Regulation
BioCentury Inc.
Mark Vaeck, Ph.D.
CEO
Complix N.V.
Jerome Van Biervliet, Ph.D.
Managing Director
VIB
Benoît van den Hove
Head of Listing, Belgium
Euronext
Lieven Van der Veken, M.D.
Senior Partner
McKinsey & Co.
Vincent Van Dessel
CEO
Euronext Brussels
Tim Van Hauwermeiren
CEO
argenx S.E.
Guillaume Vignon
SVP, Business Development
BeiGene Ltd.
Evelina Vågesjö, Ph.D.
Co-founder & CEO
Ilya Pharma AB
Mark Wegter
Managing Partner
LSP Partners
Martin Welschof, Ph.D.
CEO
BioInvent International AB
Erica Whittaker, Ph.D.
Head
UCB Ventures
Kathleen M. Williams, Ph.D.
Co-Chair, Life Sciences
Nutter McClennen & Fish LLP
Marta-Gaia Zanchi, Ph.D.
Managing Partner
Nina Capital
Alexandra Zemp, Ph.D.
Partner
McKinsey & Company